Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's cancer group study 213

R. J. Wells, D. C. Arthur, A. Srivastava, N. A. Heerema, M. Le Beau, T. A. Alonzo, A. B. Buxton, W. G. Woods, W. B. Howells, D. R. Benjamin, D. L. Betcher, J. D. Buckley, S. A. Feig, T. Kim, L. F. Odom, F. B. Ruymann, W. A. Smithson, R. Tannous, J. K. Whitt, Lawrence WolffT. Tjoa, B. C. Lampkin

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

The objective of this study was to identify biologic parameters that were associated with either exceptionally good or poor outcome in childhood acute myeloid leukemia (AML). Among the children with AML who entered Children's Cancer Group trial 213, 498 patients without Down syndrome or acute promyelocytic leukemia (APL) comprise the basis for this report. Univariate comparisons of the proportion of patients attaining complete remission after induction (CR) indicate that, at diagnosis, male gender, low platelet count (≤20 000/μl), hepatomegaly, myelodysplastic syndrome (MDS), French-American-British (FAB) category M5, high (>15%) bone marrow (BM) blasts on day 14 of the first course of induction, and +8 are associated with lower CR rates, while abnormal 16 is associated with a higher CR rate. Multivariate analysis suggests high platelet count at diagnosis (>20 000/μl), absence of hepatomegaly, ≤ 15% day 14 BM blast percentage, and abnormal 16 are independent prognostic factors associated with better CR. Univariate analysis demonstrated a significant favorable relationship between platelet count at diagnosis (>20 000/μl), absence of hepatomegaly, low percentage of BM blasts (≤15%), and abnormal 16 with overall survival. Absence of hepatomegaly, ≤15% day 14 BM blast percentage, and abnormal 16 were determined to be independent prognostic factors associated with better survival.

Original languageEnglish (US)
Pages (from-to)601-607
Number of pages7
JournalLeukemia
Volume16
Issue number4
DOIs
StatePublished - 2002

Fingerprint

Hepatomegaly
Acute Myeloid Leukemia
Bone Marrow
Platelet Count
Neoplasms
Remission Induction
Acute Promyelocytic Leukemia
Survival
Myelodysplastic Syndromes
Down Syndrome
Multivariate Analysis

Keywords

  • Childhood acute myeloid leukemia
  • Prognostic factors

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Wells, R. J., Arthur, D. C., Srivastava, A., Heerema, N. A., Le Beau, M., Alonzo, T. A., ... Lampkin, B. C. (2002). Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's cancer group study 213. Leukemia, 16(4), 601-607. https://doi.org/10.1038/sj.leu.2402502

Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia : Children's cancer group study 213. / Wells, R. J.; Arthur, D. C.; Srivastava, A.; Heerema, N. A.; Le Beau, M.; Alonzo, T. A.; Buxton, A. B.; Woods, W. G.; Howells, W. B.; Benjamin, D. R.; Betcher, D. L.; Buckley, J. D.; Feig, S. A.; Kim, T.; Odom, L. F.; Ruymann, F. B.; Smithson, W. A.; Tannous, R.; Whitt, J. K.; Wolff, Lawrence; Tjoa, T.; Lampkin, B. C.

In: Leukemia, Vol. 16, No. 4, 2002, p. 601-607.

Research output: Contribution to journalReview article

Wells, RJ, Arthur, DC, Srivastava, A, Heerema, NA, Le Beau, M, Alonzo, TA, Buxton, AB, Woods, WG, Howells, WB, Benjamin, DR, Betcher, DL, Buckley, JD, Feig, SA, Kim, T, Odom, LF, Ruymann, FB, Smithson, WA, Tannous, R, Whitt, JK, Wolff, L, Tjoa, T & Lampkin, BC 2002, 'Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's cancer group study 213', Leukemia, vol. 16, no. 4, pp. 601-607. https://doi.org/10.1038/sj.leu.2402502
Wells, R. J. ; Arthur, D. C. ; Srivastava, A. ; Heerema, N. A. ; Le Beau, M. ; Alonzo, T. A. ; Buxton, A. B. ; Woods, W. G. ; Howells, W. B. ; Benjamin, D. R. ; Betcher, D. L. ; Buckley, J. D. ; Feig, S. A. ; Kim, T. ; Odom, L. F. ; Ruymann, F. B. ; Smithson, W. A. ; Tannous, R. ; Whitt, J. K. ; Wolff, Lawrence ; Tjoa, T. ; Lampkin, B. C. / Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia : Children's cancer group study 213. In: Leukemia. 2002 ; Vol. 16, No. 4. pp. 601-607.
@article{3f065108571c40969aeda5862c756fdb,
title = "Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's cancer group study 213",
abstract = "The objective of this study was to identify biologic parameters that were associated with either exceptionally good or poor outcome in childhood acute myeloid leukemia (AML). Among the children with AML who entered Children's Cancer Group trial 213, 498 patients without Down syndrome or acute promyelocytic leukemia (APL) comprise the basis for this report. Univariate comparisons of the proportion of patients attaining complete remission after induction (CR) indicate that, at diagnosis, male gender, low platelet count (≤20 000/μl), hepatomegaly, myelodysplastic syndrome (MDS), French-American-British (FAB) category M5, high (>15{\%}) bone marrow (BM) blasts on day 14 of the first course of induction, and +8 are associated with lower CR rates, while abnormal 16 is associated with a higher CR rate. Multivariate analysis suggests high platelet count at diagnosis (>20 000/μl), absence of hepatomegaly, ≤ 15{\%} day 14 BM blast percentage, and abnormal 16 are independent prognostic factors associated with better CR. Univariate analysis demonstrated a significant favorable relationship between platelet count at diagnosis (>20 000/μl), absence of hepatomegaly, low percentage of BM blasts (≤15{\%}), and abnormal 16 with overall survival. Absence of hepatomegaly, ≤15{\%} day 14 BM blast percentage, and abnormal 16 were determined to be independent prognostic factors associated with better survival.",
keywords = "Childhood acute myeloid leukemia, Prognostic factors",
author = "Wells, {R. J.} and Arthur, {D. C.} and A. Srivastava and Heerema, {N. A.} and {Le Beau}, M. and Alonzo, {T. A.} and Buxton, {A. B.} and Woods, {W. G.} and Howells, {W. B.} and Benjamin, {D. R.} and Betcher, {D. L.} and Buckley, {J. D.} and Feig, {S. A.} and T. Kim and Odom, {L. F.} and Ruymann, {F. B.} and Smithson, {W. A.} and R. Tannous and Whitt, {J. K.} and Lawrence Wolff and T. Tjoa and Lampkin, {B. C.}",
year = "2002",
doi = "10.1038/sj.leu.2402502",
language = "English (US)",
volume = "16",
pages = "601--607",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia

T2 - Children's cancer group study 213

AU - Wells, R. J.

AU - Arthur, D. C.

AU - Srivastava, A.

AU - Heerema, N. A.

AU - Le Beau, M.

AU - Alonzo, T. A.

AU - Buxton, A. B.

AU - Woods, W. G.

AU - Howells, W. B.

AU - Benjamin, D. R.

AU - Betcher, D. L.

AU - Buckley, J. D.

AU - Feig, S. A.

AU - Kim, T.

AU - Odom, L. F.

AU - Ruymann, F. B.

AU - Smithson, W. A.

AU - Tannous, R.

AU - Whitt, J. K.

AU - Wolff, Lawrence

AU - Tjoa, T.

AU - Lampkin, B. C.

PY - 2002

Y1 - 2002

N2 - The objective of this study was to identify biologic parameters that were associated with either exceptionally good or poor outcome in childhood acute myeloid leukemia (AML). Among the children with AML who entered Children's Cancer Group trial 213, 498 patients without Down syndrome or acute promyelocytic leukemia (APL) comprise the basis for this report. Univariate comparisons of the proportion of patients attaining complete remission after induction (CR) indicate that, at diagnosis, male gender, low platelet count (≤20 000/μl), hepatomegaly, myelodysplastic syndrome (MDS), French-American-British (FAB) category M5, high (>15%) bone marrow (BM) blasts on day 14 of the first course of induction, and +8 are associated with lower CR rates, while abnormal 16 is associated with a higher CR rate. Multivariate analysis suggests high platelet count at diagnosis (>20 000/μl), absence of hepatomegaly, ≤ 15% day 14 BM blast percentage, and abnormal 16 are independent prognostic factors associated with better CR. Univariate analysis demonstrated a significant favorable relationship between platelet count at diagnosis (>20 000/μl), absence of hepatomegaly, low percentage of BM blasts (≤15%), and abnormal 16 with overall survival. Absence of hepatomegaly, ≤15% day 14 BM blast percentage, and abnormal 16 were determined to be independent prognostic factors associated with better survival.

AB - The objective of this study was to identify biologic parameters that were associated with either exceptionally good or poor outcome in childhood acute myeloid leukemia (AML). Among the children with AML who entered Children's Cancer Group trial 213, 498 patients without Down syndrome or acute promyelocytic leukemia (APL) comprise the basis for this report. Univariate comparisons of the proportion of patients attaining complete remission after induction (CR) indicate that, at diagnosis, male gender, low platelet count (≤20 000/μl), hepatomegaly, myelodysplastic syndrome (MDS), French-American-British (FAB) category M5, high (>15%) bone marrow (BM) blasts on day 14 of the first course of induction, and +8 are associated with lower CR rates, while abnormal 16 is associated with a higher CR rate. Multivariate analysis suggests high platelet count at diagnosis (>20 000/μl), absence of hepatomegaly, ≤ 15% day 14 BM blast percentage, and abnormal 16 are independent prognostic factors associated with better CR. Univariate analysis demonstrated a significant favorable relationship between platelet count at diagnosis (>20 000/μl), absence of hepatomegaly, low percentage of BM blasts (≤15%), and abnormal 16 with overall survival. Absence of hepatomegaly, ≤15% day 14 BM blast percentage, and abnormal 16 were determined to be independent prognostic factors associated with better survival.

KW - Childhood acute myeloid leukemia

KW - Prognostic factors

UR - http://www.scopus.com/inward/record.url?scp=85014302266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014302266&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2402502

DO - 10.1038/sj.leu.2402502

M3 - Review article

C2 - 11960339

AN - SCOPUS:85014302266

VL - 16

SP - 601

EP - 607

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 4

ER -